{"id":"https://openalex.org/W90183276","doi":null,"title":"\u0414\u0430\u043d\u043d\u044b\u0435 \u0430\u043d\u0430\u043b\u0438\u0437\u0430 \u0430\u043c\u0431\u0443\u043b\u0430\u0442\u043e\u0440\u043d\u043e\u0439 \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u043d\u0435\u043a\u043e\u0442\u043e\u0440\u044b\u043c\u0438 \u0433\u0438\u043f\u043e\u0442\u0435\u043d\u0437\u0438\u0432\u043d\u044b\u043c\u0438 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u0430\u043c\u0438 \u0441 \u043f\u043e\u043c\u043e\u0449\u044c\u044e \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0438 \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u044d\u043a\u043e\u043d\u043e\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043c\u0435\u0442\u043e\u0434\u043e\u0432","display_name":"\u0414\u0430\u043d\u043d\u044b\u0435 \u0430\u043d\u0430\u043b\u0438\u0437\u0430 \u0430\u043c\u0431\u0443\u043b\u0430\u0442\u043e\u0440\u043d\u043e\u0439 \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u043d\u0435\u043a\u043e\u0442\u043e\u0440\u044b\u043c\u0438 \u0433\u0438\u043f\u043e\u0442\u0435\u043d\u0437\u0438\u0432\u043d\u044b\u043c\u0438 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u0430\u043c\u0438 \u0441 \u043f\u043e\u043c\u043e\u0449\u044c\u044e \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0438 \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u044d\u043a\u043e\u043d\u043e\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043c\u0435\u0442\u043e\u0434\u043e\u0432","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W90183276","mag":"90183276"},"language":"ru","primary_location":{"id":"mag:90183276","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/dannye-analiza-ambulatornoy-farmakoterapii-nekotorymi-gipotenzivnymi-sredstvami-s-pomoschyu-farmakoepidemiologicheskih-i.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306539131","display_name":"\u0416\u0443\u0440\u043d\u0430\u043b \u0413\u0440\u043e\u0434\u043d\u0435\u043d\u0441\u043a\u043e\u0433\u043e \u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442\u0430","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u0416\u0443\u0440\u043d\u0430\u043b \u0413\u0440\u043e\u0434\u043d\u0435\u043d\u0441\u043a\u043e\u0433\u043e \u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442\u0430","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W90183276"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018302271","display_name":"\u0412. \u041f. \u0412\u0434\u043e\u0432\u0438\u0447\u0435\u043d\u043a\u043e","orcid":"https://orcid.org/0009-0009-6739-6154","observed_orcids":["https://orcid.org/0009-0009-6739-6154"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0412. \u041f. \u0412\u0434\u043e\u0432\u0438\u0447\u0435\u043d\u043a\u043e","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006848654","display_name":"\u0413. \u041c. \u0411\u0440\u043e\u043d\u0441\u043a\u0430\u044f","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0413. \u041c. \u0411\u0440\u043e\u043d\u0441\u043a\u0430\u044f","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067201348","display_name":"\u0422. \u0410. \u041a\u043e\u0440\u0448\u0430\u043a","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0422. \u0410. \u041a\u043e\u0440\u0448\u0430\u043a","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065585713","display_name":"\u0414. \u0421. \u0416\u0443\u043a\u043e\u0432\u0441\u043a\u0438\u0439","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0414. \u0421. \u0416\u0443\u043a\u043e\u0432\u0441\u043a\u0438\u0439","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087116172","display_name":"\u0420. \u041c. \u0421\u0430\u043b\u043c\u0438\u043d","orcid":"https://orcid.org/0000-0002-6625-8499","observed_orcids":["https://orcid.org/0000-0002-6625-8499"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0420. \u041c. \u0421\u0430\u043b\u043c\u0438\u043d","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028372657","display_name":"\u0412. \u0412. \u0412\u0430\u0449\u0435\u043d\u043a\u043e","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0412. \u0412. \u0412\u0430\u0449\u0435\u043d\u043a\u043e","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14108","display_name":"Medical and Pharmaceutic Studies","score":0.017000000923871994,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8849999904632568},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.8790000081062317},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9890000224113464},{"id":"https://openalex.org/keywords/furosemide","display_name":"furosemide","score":0.878000020980835},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/spironolactone","display_name":"spironolactone","score":1.0},{"id":"https://openalex.org/keywords/indapamide","display_name":"indapamide","score":1.0},{"id":"https://openalex.org/keywords/cost-minimization-analysis","display_name":"cost-minimization analysis","score":0.8090000152587891},{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.7889999747276306},{"id":"https://openalex.org/keywords/hypertensive-crisis","display_name":"hypertensive crisis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/clonidine","display_name":"clonidine","score":0.9459999799728394},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C2780361556","wikidata":"https://www.wikidata.org/wiki/Q423930","display_name":"Hydrochlorothiazide","level":3,"score":0.8886334896087646},{"id":"https://openalex.org/C2777748223","wikidata":"https://www.wikidata.org/wiki/Q1078392","display_name":"Indapamide","level":3,"score":0.8762773871421814},{"id":"https://openalex.org/C2776379505","wikidata":"https://www.wikidata.org/wiki/Q422188","display_name":"Spironolactone","level":3,"score":0.7650105953216553},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7360646724700928},{"id":"https://openalex.org/C2779918671","wikidata":"https://www.wikidata.org/wiki/Q200656","display_name":"Diuretic","level":2,"score":0.729860782623291},{"id":"https://openalex.org/C2777955127","wikidata":"https://www.wikidata.org/wiki/Q388801","display_name":"Furosemide","level":2,"score":0.6750696301460266},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5381117463111877},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5330366492271423},{"id":"https://openalex.org/C2777622974","wikidata":"https://www.wikidata.org/wiki/Q221520","display_name":"Triamterene","level":4,"score":0.48307374119758606},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.4278082549571991},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4059472680091858},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32747167348861694},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.312652587890625},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.21963274478912354},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.1932639181613922}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:90183276","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/dannye-analiza-ambulatornoy-farmakoterapii-nekotorymi-gipotenzivnymi-sredstvami-s-pomoschyu-farmakoepidemiologicheskih-i.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306539131","display_name":"\u0416\u0443\u0440\u043d\u0430\u043b \u0413\u0440\u043e\u0434\u043d\u0435\u043d\u0441\u043a\u043e\u0433\u043e \u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442\u0430","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u0416\u0443\u0440\u043d\u0430\u043b \u0413\u0440\u043e\u0434\u043d\u0435\u043d\u0441\u043a\u043e\u0433\u043e \u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442\u0430","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W422032638","https://openalex.org/W1597905768","https://openalex.org/W10976272","https://openalex.org/W57088331","https://openalex.org/W2883960373","https://openalex.org/W1669513903","https://openalex.org/W2393577062","https://openalex.org/W53029092","https://openalex.org/W190697073"],"abstract_inverted_index":{"Obtaining":[0],"of":[1,11,14,26,33,47,58,61,64,84,95,99,112,118,125,130,137,143,146,150,162,168,175,180,195,212],"some":[2,17,121],"pharmacoepidemiological":[3],"data,":[4],"including":[5],"the":[6,9,31,34,38,44,56,59,82,100,159,163,165,176,188],"list":[7,167],"and":[8,16,55,91,200,210],"rate":[10],"out\u2013patient":[12,49],"use":[13,129,136,149],"diuretics":[15,85,103,199],"other":[18],"(including":[19],"\u00abtraditional\u00bb)":[20],"hypotensive":[21],"drugs":[22,80,139,154],"employed":[23],"in":[24,37,97,104],"treatment":[25,192,194,211],"arterial":[27],"hypertension":[28],"(AH)":[29],"was":[30],"goal":[32],"present":[35],"work":[36],"first":[39],"stage.":[40],"For":[41],"this":[42],"purpose":[43],"retrospective":[45],"analysis":[46],"664":[48],"case":[50],"histories":[51],"(Grodno,":[52,66],"Kobrin,":[53],"Shchuchin)":[54],"results":[57],"questioning":[60],"118":[62],"doctors":[63,122],"polyclinics":[65],"Gomel,":[67],"Zhlobin)":[68],"has":[69,74,106,170,184],"been":[70,75,107,171,185],"carried":[71],"out.":[72],"It":[73,183],"revealed,":[76,186],"that":[77,187],"only":[78],"four":[79],"from":[81],"group":[83],"were":[86],"used:":[87],"furosemide,":[88],"hydrochlorothiazide,":[89],"spironolactone":[90,131],"indapamide.":[92],"The":[93,109,148],"tendency":[94],"increase":[96],"quantity":[98],"patients":[101],"receiving":[102],"AH":[105,196],"revealed.":[108],"essential":[110],"drawbacks":[111],"pharmacotherapy":[113],"however":[114],"remain:":[115],"1)":[116],"preference":[117],"furosemide":[119],"by":[120,173],"(probably":[123],"because":[124],"its":[126],"cheapness);":[127],"2)":[128],"for":[132],"monotherapy;":[133],"3)":[134],"insufficient":[135],"modern":[138],"(indapamide);":[140],"4)":[141],"administration":[142],"low":[144],"doses":[145],"diuretics.":[147],"so\u2013called":[151],"\u00abtraditional\u00bb":[152,207],"antihypertensive":[153,208],"remains":[155],"rather":[156],"high.":[157],"In":[158],"second":[160],"stage":[161],"investigation":[164],"received":[166],"preparations":[169],"estimated":[172],"means":[174],"standard":[177],"pharmacoeconomic":[178],"technique":[179],"\u00abcost\u2013minimization":[181],"analysis\u00bb.":[182],"most":[189],"economically":[190],"grounded":[191],"is":[193],"with":[197,201,215],"hydrochlorothiazide":[198],"Adelphane":[202],"\u2014":[203],"Esidrex":[204],"as":[205],"a":[206],"drug":[209],"hypertensive":[213],"crises":[214],"clonidine.":[216]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W90183276","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
